论文部分内容阅读
目的研究3种他汀类药物对治疗高脂血症所产生的成本-效果。方法将109例高脂血症患者随机分为A(瑞舒伐他汀)、B(阿托伐他汀)、C(辛伐他汀)3组,观察各组疗效,并进行成本-效果分析。结果 A、B、C的有效率分别为90.91%,88.23%,88.10%(P>0.05),成本分别为259.28,303.20,171.92元,成本-效果比分别为285.20,343.65,195.14。结论辛伐他汀是治疗高脂血症的较佳药物。
Objective To study the cost-effectiveness of three statins in the treatment of hyperlipidemia. Methods 109 patients with hyperlipidemia were randomly divided into three groups: A (rosuvastatin), B (atorvastatin) and C (simvastatin). The curative effect of each group was observed and the cost-effectiveness analysis was performed. Results The effective rates of A, B and C were 90.91%, 88.23% and 88.10% respectively (P> 0.05). The costs were respectively 259.28 and 303.20 and 171.92 yuan, and the cost-effectiveness ratios were 285.20, 343.65 and 195.14 respectively. Conclusion Simvastatin is a better treatment for hyperlipidemia.